Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SLIGRL-NH2 TFA, also known as Protease-Activated Receptor-2 Activating Peptide TFA, is a Protease-Activated Receptor-2 (PAR-2) agonist [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | SLIGRL-NH2 TFA, also known as Protease-Activated Receptor-2 Activating Peptide TFA, is a Protease-Activated Receptor-2 (PAR-2) agonist [1]. |
In vitro | SLIGRL-NH2 serves as an agonist for both PAR-2 and MrgprC11 [1]. It induces a relaxation that is inhibited by L-NAME, suggesting a nitric oxide-dependent mechanism. Importantly, SLIGRL-NH2 achieves a concentration-dependent relaxation with an EC50 of 10 µM in endothelium-free preparations when accompanied by perivascular adipose tissue (PVAT). Consequently, a concentration of 20 µM is selected for further experiments to assess the influence of inhibitors on ADRF release and activity. In endothelium-denuded aortic preparations, the peptide solely elicits this concentration-dependent relaxation in conjunction with PVAT [+PVAT, -ENDO (endothelium)] [2]. |
Synonyms | Protease-Activated Receptor-2 Activating Peptide TFA |
Molecular Weight | 770.84 |
Formula | C31H57F3N10O9 |
CAS No. | 2828432-39-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SLIGRL-NH2 TFA 2828432-39-7 Protease-Activated Receptor-2 Activating Peptide TFA inhibitor inhibit